tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BCRX Stock Latest News

BioCryst reports inducement grants under Nasdaq listing rule
The FlyBioCryst reports inducement grants under Nasdaq listing rule
16h ago
BCRX
BioCryst’s Earnings Call Highlights Strong Growth and Strategic Moves
PremiumCompany Announcements
BioCryst’s Earnings Call Highlights Strong Growth and Strategic Moves
1d ago
BCRX
BioCryst’s Orladeyo: Strong Market Outlook and Strategic Expansion Drive Buy Rating
PremiumRatings
BioCryst’s Orladeyo: Strong Market Outlook and Strategic Expansion Drive Buy Rating
2d ago
BCRX
BioCryst Pharmaceuticals Reports Record Q2 2025 Results
PremiumCompany Announcements
BioCryst Pharmaceuticals Reports Record Q2 2025 Results
2d ago
BCRX
BioCryst’s Strong Q2 Performance and Unique Market Position Justify Buy Rating
PremiumRatings
BioCryst’s Strong Q2 Performance and Unique Market Position Justify Buy Rating
2d ago
BCRX
BioCryst’s Strong Performance and Growth Potential Justifies Buy Rating
PremiumRatingsBioCryst’s Strong Performance and Growth Potential Justifies Buy Rating
2d ago
BCRX
BioCryst Reports Strong Q2 2025 Financial Performance
Premium
Company Announcements
BioCryst Reports Strong Q2 2025 Financial Performance
3d ago
8K
BCRX
BioCryst reaffirms FY25 ORLADEYO revenue view $580M-$600M
Premium
The Fly
BioCryst reaffirms FY25 ORLADEYO revenue view $580M-$600M
3d ago
BCRX
BioCryst reports Q2 EPS 15c, consensus 3c
PremiumThe Fly
BioCryst reports Q2 EPS 15c, consensus 3c
3d ago
BCRX
BCRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
BCRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5d ago
BCRX
BioCryst Announces New President Amid Leadership Change
PremiumCompany Announcements
BioCryst Announces New President Amid Leadership Change
7d ago
8K
BCRX
BioCryst announces planned retirement of CEO Stonehouse, Gayer to succeed
PremiumThe Fly
BioCryst announces planned retirement of CEO Stonehouse, Gayer to succeed
7d ago
BCRX
BioCryst Pharmaceuticals’ BCX9930 Study Termination: Implications for Investors
PremiumCompany AnnouncementsBioCryst Pharmaceuticals’ BCX9930 Study Termination: Implications for Investors
27d ago
BCRX
BioCryst Appoints New CFO to Drive Growth
Premium
Company Announcements
BioCryst Appoints New CFO to Drive Growth
1M ago
8K
BCRX
BioCryst appoints Babar Ghias as CFO, head of corporate development
Premium
The Fly
BioCryst appoints Babar Ghias as CFO, head of corporate development
1M ago
BCRX
BioCryst reports inducement grants under Nasdaq listing rule
PremiumThe Fly
BioCryst reports inducement grants under Nasdaq listing rule
1M ago
BCRX
BioCryst price target raised to $15 from $13 at BofA
PremiumThe Fly
BioCryst price target raised to $15 from $13 at BofA
1M ago
BCRX
BioCryst’s Strategic Sale and Debt Retirement Strengthen Financial Position and Justify Buy Rating
PremiumRatings
BioCryst’s Strategic Sale and Debt Retirement Strengthen Financial Position and Justify Buy Rating
1M ago
BCRX
BioCryst Sells BioCryst Ireland to Neopharmed Gentili
PremiumCompany Announcements
BioCryst Sells BioCryst Ireland to Neopharmed Gentili
1M ago
8K
BCRX
BioCryst price target raised to $18 from $16 at Wedbush
PremiumThe FlyBioCryst price target raised to $18 from $16 at Wedbush
1M ago
BCRX
BioCryst Sells European ORLADEYO Business for $264M
Premium
Company Announcements
BioCryst Sells European ORLADEYO Business for $264M
1M ago
8K
BCRX
BioCryst to sell its European ORLADEYO busines to Neopharmed for up to $264M
Premium
The Fly
BioCryst to sell its European ORLADEYO busines to Neopharmed for up to $264M
1M ago
BCRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >